Literature DB >> 2458916

Dexamethasone reduces steady state insulin-like growth factor I messenger ribonucleic acid levels in rat neuronal and glial cells in primary culture.

M Adamo1, H Werner, W Farnsworth, C T Roberts, M Raizada, D LeRoith.   

Abstract

Insulin-like growth factor I (IGF-I) mRNA was demonstrated in primary cultures of neuronal and glial cells from rat brain. On Northern blots, a rat IGF-I cDNA probe hybridized to RNA species of 7.5, 1.7, and 0.8-1.2 kilobases in total and poly(A)+ RNA from both cell types. Solution hybridization/RNase protection assays were performed using an antisense riboprobe complementary to the 5'-untranslated region as well as part of the coding region of rat IGF-I mRNA. These studies indicated that two of the previously described three possible alternative 5'-untranslated splicing variants (classes A and C) were expressed in neuronal and glial cells, with class C transcripts predominating. Neuronal cells also possessed extremely low levels of class B transcripts. Treatment of neuronal cell cultures with the synthetic glucocorticoid dexamethasone reduced IGF-I mRNA levels by 60%. Glial cell IGF-I mRNA levels were reduced by dexamethasone by up to 40%. These results suggest that glucocorticoid-induced reductions in IGF-I production could occur at the level of transcription and may underlie some of the actions of glucocorticoids in causing growth retardation and inhibition of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458916     DOI: 10.1210/endo-123-5-2565

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Molecular biology of the insulin-like growth factors. Relevance to nervous system function.

Authors:  J E Hepler; P K Lund
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

Review 2.  Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1.

Authors:  Ferenc Deak; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-12       Impact factor: 6.053

3.  Insulin-like growth factor I stimulates dendritic growth in primary somatosensory cortex.

Authors:  M M Niblock; J K Brunso-Bechtold; D R Riddle
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 4.  The role of the insulin-like growth factors in the central nervous system.

Authors:  A J D'Ercole; P Ye; A S Calikoglu; G Gutierrez-Ospina
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

Review 5.  Insulin and insulin-like growth factor receptors in the nervous system.

Authors:  M Adamo; M K Raizada; D LeRoith
Journal:  Mol Neurobiol       Date:  1989 Spring-Summer       Impact factor: 5.590

6.  Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats.

Authors:  O Schakman; S Kalista; L Bertrand; P Lause; J Verniers; J M Ketelslegers; J P Thissen
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

7.  A single course of prenatal betamethasone in the rat alters postnatal brain cell proliferation but not apoptosis.

Authors:  Arjan Scheepens; Marjo van de Waarenburg; Daniël van den Hove; Carlos E Blanco
Journal:  J Physiol       Date:  2003-08-08       Impact factor: 5.182

8.  Effects of antenatal glucocorticoid therapy on hippocampal histology of preterm infants.

Authors:  Deodata Tijsseling; Lia D E Wijnberger; Jan B Derks; Cindy T J van Velthoven; Willem B de Vries; Frank van Bel; Peter G J Nikkels; Gerard H A Visser
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

9.  Insulin-like growth factor I and the pathogenesis of delirium: a review of current evidence.

Authors:  Dimitrios Adamis; David Meagher
Journal:  J Aging Res       Date:  2011-07-03

10.  Insulin-like growth factor-1 in CNS and cerebrovascular aging.

Authors:  William E Sonntag; Ferenc Deak; Nicole Ashpole; Peter Toth; Anna Csiszar; Willard Freeman; Zoltan Ungvari
Journal:  Front Aging Neurosci       Date:  2013-07-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.